(Q36080032)

12 August 2017

Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group (English)

1 reference

12 August 2017

phase II clinical trial

0 references

1 reference

A Sulkes

1

1 reference

12 August 2017

J Smyth

2

1 reference

12 August 2017

C Sessa

3

1 reference

12 August 2017

L Y Dirix

4

1 reference

12 August 2017

J B Vermorken

5

1 reference

12 August 2017

S Kaye

6

1 reference

12 August 2017

J Wanders

7

1 reference

12 August 2017

H Franklin

8

1 reference

12 August 2017

N LeBail

9

1 reference

12 August 2017

J Verweij

10

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 1994

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

70

1 reference

12 August 2017

2

1 reference

12 August 2017

380-383

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1994.310

12 August 2017

0 references

cites work

5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033505

Chemotherapy of gastric cancer: a review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033505

Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033505

Relationships between the structure of taxol analogs and their antimitotic activity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033505

11 July 2018

Cancer statistics, 1985

1 reference

12 December 2020

An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer

1 reference

12 December 2020

5-Fluorouracil, doxorubicin (adriamycin) and mitomycin-C (FAM) in advanced gastric cancer: observations on response, patient characteristics, myelosuppression and delivered dosage

1 reference

12 December 2020

EAP in advanced gastric cancer

1 reference

12 December 2020

Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue

1 reference

12 December 2020

Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1994.310

1 reference

12 August 2017

1 reference

12 August 2017

1 reference